Drugs such as NSI-189, Dihexa, and Cerebrolysin are often touted as the big guns of nootropics due to their tendecy to induce neurogenesis through one manner or another.
GM-604 also appears to do so through several known mechanisms (better known than say, NSI-189) through the same mechanism by which it slows ALS. perhaps it could even slow the normal aging decline, which remains a key point in both nootropics and life extension.
It's structure is Phenylalanine-Serine-Arginine-Tyrosine-Alanine-Arginine. this was pulled from the patent documentation as the code FSRYAR, and converted to amino acids using the single letter code. there is also a picture of the drug on Genevron's website.
http://www.google.co...2086331A2?cl=en
http://www.genervon....development.php
Any interest? Info? Experiences? Sources?